NCT06668415 Effects of Spencer Technique Following Hydrodilation in Patients With Adhesive Capsulitis
| NCT ID | NCT06668415 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Adhesive Capsulitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-07-20 |
| Primary Completion | 2024-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-07-20 with a primary completion date of 2024-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adhesive Capsulitis is a common Musculoskeletal disorder characterized by pain and progressive joint restriction in capsular pattern. Adhesive capsulitis can be managed by both conservative and non conservative treatment. The Spencer technique and hydrodilation are two treatment approaches used to restore range of motion in adhesive capsulitis. The Spencer technique is a form of physical therapy that involves joint mobilizations and manual stretching exercises. It aims to improve shoulder mobility and reduce pain by addressing the tightness and stiffness in the shoulder capsule and surrounding tissues. Hydrodilation, on the other hand, is a procedure where a saline solution is injected into the shoulder joint to distend the capsule. This distention helps stretch the tight tissues and break up adhesions, facilitating improved range of motion.
Eligibility Criteria
Inclusion Criteria: * Patients with diagnosed unilateral Adhesive Capsulitis and have undergone Hydrodilation. --Includes both genders * Age 40 to 60 years. Exclusion Criteria * Population who have recently undergone major shoulder injury or surgery, had fracture or open wound or there is reduction of Glen humeral ROM due to any other cause other than Adhesive Capsulitis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06668415 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06668415 currently recruiting?
Yes, NCT06668415 is actively recruiting participants. Contact the research team at javeria.ilyas95@gmail.com for enrollment information.
Where is the NCT06668415 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT06668415 clinical trial?
NCT06668415 is sponsored by Foundation University Islamabad. The trial plans to enroll 30 participants.